Mattias Karlsson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Mattias Karlsson has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
- Gregor Reid
Canadian R&D Centre for Human Microbiome and Probiotics, Lawson Health Research Institute, London, ON N6A 4V2, Canada
1 shared publication - Jana Jass
The Life Science Center-Biology, School of Science and Technology, Örebro University, SE-701 82 Örebro, Sweden
1 shared publication - Nikolai Scherbak
School of Science and Technology, Life Science Center, Örebro University, Örebro, Sweden
1 shared publication
Latest Publications
- Open Access
- 22 January 2012
- Published by Springer Nature in BMC Microbiology
- Vol. 12 (1) , 15
Lactobacillus rhamnosus GR-1 enhances NF-kappaB activation in Escherichia coli-stimulated urinary bladder cells through TLR4
Background: Epithelial cells of the urinary tract recognize pathogenic bacteria through pattern recognition receptors on their surface, such as toll-like receptors (TLRs), and mount an immune response through the activation of the NF-kappaB pathway. Some uropathogenic bacteria can subvert these cellular responses, creating problems with how the host eliminates pathogens.Lactobacillusis a genus of lactic acid bacteria that are part of the microbiota and consist of many probiotic strains, some specifically for urogenital infections. Immunomodulation has emerged as an important mode of action of probiotic and commensal lactobacilli and given the importance of epithelial cells, we evaluated the effect of the urogenital probioticLactobacillus rhamnosusGR-1 on epithelial immune activation.Results: Immune activation through the NF-kappaB pathway was initiated by stimulation of T24 urothelial cells with heat-killedEscherichia coliand this was further potentiated when cells were co-cultured with liveL. rhamnosusGR-1. Heat-killed lactobacilli were poor activators of NF-kappaB. Concomitant stimulation of bladder cells withE. coliandL. rhamnosusGR-1 increased the levels of the pro-inflammatory cytokine TNF, whereas IL-6 and CXCL8 levels were reduced. Another probiotic,L. rhamnosusGG, was also able to potentiate NF-kappaB in these cells although at a significantly reduced level compared to the GR-1 strain. The transcript numbers and protein levels of the lipopolysaccharide receptor TLR4 were significantly increased after co-stimulation withE. coliand lactobacilli compared to controls. Furthermore, inhibition of TLR4 activation by polymixin B completely blocked the lactobacilli potentiation of NF-kappaB.Conclusions: The immunological outcome ofE. colichallenge of bladder cells was influenced by probioticL. rhamnosusGR-1, by enhancing the activation of NF-kappaB and TNF release. Thus the urogenital probioticL. rhamnosusGR-1 modulated the activation of the NF-kappaB through increased levels of TLR4 on the bladder cells and altered subsequent release of cytokines from urothelial cells. By influencing immunological factors such as TLR4, important in the process of fighting pathogens, lactobacilli could facilitate pathogen recognition and infection clearance.
- 22 January 2012
- Published by Springer Nature in BMC Microbiology
- Vol. 12 (1) , 15
Open AccessLactobacillus rhamnosus GR-1 enhances NF-kappaB activation in Escherichia coli-stimulated urinary bladder cells through TLR4
Background: Epithelial cells of the urinary tract recognize pathogenic bacteria through pattern recognition receptors on their surface, such as toll-like receptors (TLRs), and mount an immune response through the activation of the NF-kappaB pathway. Some uropathogenic bacteria can subvert these cellular responses, creating problems with how the host eliminates pathogens.Lactobacillusis a genus of lactic acid bacteria that are part of the microbiota and consist of many probiotic strains, some specifically for urogenital infections. Immunomodulation has emerged as an important mode of action of probiotic and commensal lactobacilli and given the importance of epithelial cells, we evaluated the effect of the urogenital probioticLactobacillus rhamnosusGR-1 on epithelial immune activation.Results: Immune activation through the NF-kappaB pathway was initiated by stimulation of T24 urothelial cells with heat-killedEscherichia coliand this was further potentiated when cells were co-cultured with liveL. rhamnosusGR-1. Heat-killed lactobacilli were poor activators of NF-kappaB. Concomitant stimulation of bladder cells withE. coliandL. rhamnosusGR-1 increased the levels of the pro-inflammatory cytokine TNF, whereas IL-6 and CXCL8 levels were reduced. Another probiotic,L. rhamnosusGG, was also able to potentiate NF-kappaB in these cells although at a significantly reduced level compared to the GR-1 strain. The transcript numbers and protein levels of the lipopolysaccharide receptor TLR4 were significantly increased after co-stimulation withE. coliand lactobacilli compared to controls. Furthermore, inhibition of TLR4 activation by polymixin B completely blocked the lactobacilli potentiation of NF-kappaB.Conclusions: The immunological outcome ofE. colichallenge of bladder cells was influenced by probioticL. rhamnosusGR-1, by enhancing the activation of NF-kappaB and TNF release. Thus the urogenital probioticL. rhamnosusGR-1 modulated the activation of the NF-kappaB through increased levels of TLR4 on the bladder cells and altered subsequent release of cytokines from urothelial cells. By influencing immunological factors such as TLR4, important in the process of fighting pathogens, lactobacilli could facilitate pathogen recognition and infection clearance.